# Hydroxychloroquine for Treatment of Non-Severe COVID-19

> **NCT04860284** · PHASE2 · UNKNOWN · sponsor: **Makerere University** · enrollment: 105 (actual)

## Conditions studied

- Covid19

## Interventions

- **DRUG:** Hydroxychloroquine tablets

## Key facts

- **NCT ID:** NCT04860284
- **Lead sponsor:** Makerere University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09-18
- **Primary completion:** 2021-02-09
- **Final completion:** 2021-12-01
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2021-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04860284

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04860284, "Hydroxychloroquine for Treatment of Non-Severe COVID-19". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04860284. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*